DOVPRELA 200 mg, tablet 26 tablets
Active ingredients: PRÉTOMANID
Commercialized according to BDPMDispensing in France: Prescription only
Tablet26 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DOVPRELA 200 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) de 26 comprimé(s)
- Marketing authorisation holder
- MYLAN IRE HEALTHCARE (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 Oct 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
63915869CIP73022471CIP133400930224717Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PRÉTOMANIDcomprimé | 200 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.